Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126019281 | 12601928 | 1 | I | 201604 | 20160726 | 20160728 | 20160728 | EXP | FR-ROCHE-1803182 | ROCHE | 59.00 | YR | F | Y | 0.00000 | 20160728 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126019281 | 12601928 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous drip | DAY 1 | U | 103705 | 1 | DF | SOLUTION FOR INFUSION | QD | |||||
| 126019281 | 12601928 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous drip | DAY 15 | U | 103705 | 1 | DF | SOLUTION FOR INFUSION | QD | |||||
| 126019281 | 12601928 | 3 | SS | SOLUPRED (FRANCE) | PREDNISOLONE | 1 | Oral | U | 0 | 30 | MG | QD | |||||||
| 126019281 | 12601928 | 4 | C | KARDEGIC | ASPIRIN LYSINE | 1 | 0 | ||||||||||||
| 126019281 | 12601928 | 5 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 0 | ||||||||||||
| 126019281 | 12601928 | 6 | C | ALTEIS | OLMESARTAN MEDOXOMIL | 1 | 0 | ||||||||||||
| 126019281 | 12601928 | 7 | C | FOSAVANCE | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126019281 | 12601928 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126019281 | 12601928 | 9 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 126019281 | 12601928 | 10 | C | NOVORAPID | INSULIN ASPART | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126019281 | 12601928 | 1 | Limbic encephalitis |
| 126019281 | 12601928 | 2 | Systemic lupus erythematosus |
| 126019281 | 12601928 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126019281 | 12601928 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126019281 | 12601928 | Neuropathy peripheral | |
| 126019281 | 12601928 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126019281 | 12601928 | 1 | 20160111 | 20160111 | 0 | |
| 126019281 | 12601928 | 2 | 20160116 | 20160116 | 0 |